Data gathered: April 15
AI Stock Analysis - Resmed (RMD)
Analysis generated March 20, 2025. Powered by Chat GPT.
Resmed, an internationally renowned player in the health care sector, specializes in innovative respiratory care solutions. The company's product portfolio includes devices and software solutions for diagnosing, treating, and managing sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed's consistent thrust on R&D has enabled it to develop advanced products that improve patients' lives and reduce healthcare costs. Headquartered in San Diego, California, Resmed operates in over 140 countries.
Stock Alerts - Resmed (RMD)
 |
Resmed | April 11 Insider Alert: Sandercock Brett is selling shares |
|
Resmed | April 10 Insider Alert: Farrell Michael J. is selling shares |
|
Resmed | April 9 Price is up by 5.5% in the last 24h. |
|
Resmed | April 7 Price is up by 5.3% in the last 24h. |
Alternative Data for Resmed
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 337 | Sign up | Sign up | Sign up |
| Sentiment | 95 | Sign up | Sign up | Sign up |
| Webpage traffic | 3,278,000 | Sign up | Sign up | Sign up |
| Employee Rating | 82 | Sign up | Sign up | Sign up |
| Google Trends | 88 | Sign up | Sign up | Sign up |
| Patents | 840 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 191 | Sign up | Sign up | Sign up |
| Facebook Followers | 165,847 | Sign up | Sign up | Sign up |
| Instagram Followers | 7,166 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,651 | Sign up | Sign up | Sign up |
| Twitter Followers | 10,531 | Sign up | Sign up | Sign up |
| Twitter Mentions | 9 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 50,000 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 77 | Sign up | Sign up | Sign up |
| Linkedin Employees | 8,112 | Sign up | Sign up | Sign up |
About Resmed
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
| Price | $214.53 |
| Target Price | Sign up |
| Volume | 1,750,000 |
| Market Cap | $31.4B |
| Year Range | $204.54 - $257.08 |
| Dividend Yield | 0.99% |
| PE Ratio | 25.26 |
| Analyst Rating | 50% buy |
| Earnings Date | April 23 '25 |
| Industry | Medical Devices |
In the news
 |
Strength Seen in ResMed (RMD): Can Its 3.8% Jump Turn into More Strength?April 7 - Yahoo |
 |
Peter C. Farrell Sells 2,000 Shares of ResMed Inc. (NYSE:RMD) StockApril 7 - ETF Daily News |
|
Head to Head Comparison: ResMed (NYSE:RMD) and Sigyn Therapeutics (OTCMKTS:SIGY)April 4 - ETF Daily News |
 |
ResMed (NYSE:RMD) Cut to “Hold” at StockNews.comApril 4 - ETF Daily News |
ResMed Inc. (RMD): A Bull Case TheoryApril 3 - Yahoo Entertainment |
|
|
ResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across USApril 3 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '24 | 1.28B | 531M | 751M | 345M | 362M | 2.430 |
| Q3 '24 | 1.22B | 507M | 717M | 311M | 443M | 2.200 |
| Q2 '24 | 1.22B | 519M | 704M | 292M | 422M | 2.080 |
| Q1 '24 | 1.2B | 515M | 682M | 300M | 429M | 2.130 |
| Q4 '23 | 1.16B | 516M | 647M | 209M | 393M | 1.880 |
Insider Transactions View All
| Sandercock Brett filed to sell 89,864 shares at $215.6. April 10 '25 |
| Farrell Michael J. filed to sell 455,472 shares at $209.9. April 9 '25 |
| FARRELL PETER C filed to sell 73,218 shares at $219.7. April 4 '25 |
| Rider Michael J filed to sell 8,846 shares at $222.9. April 3 '25 |
| Ghoshal Kaushik filed to sell 9,725 shares at $239.3. March 11 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$94.27 0% | 72 |
 |
Edwards LifesciencesEW |
$69.87 0% | 32 |
 |
Intuitive SurgicalISRG |
$490.13 0% | 66 |
 |
MedtronicMDT |
$84.22 0% | 47 |
 |
StrykerSYK |
$353.42 0% | 48 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ro Khanna |
Dec 6, 24 | Buy | $1K - $15K |
| Thomas Tuberville Republican |
Nov 16, 23 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
Read more about Resmed (RMD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Resmed?
The Market Cap of Resmed is $31.4B.
What is Resmed's PE Ratio?
As of today, Resmed's PE (Price to Earnings) ratio is 25.26.
When does Resmed report earnings?
Resmed will report its next earnings on April 23 '25.
What is the current stock price of Resmed?
Currently, the price of one share of Resmed stock is $214.53.
How can I analyze the RMD stock price chart for investment decisions?
The RMD stock price chart above provides a comprehensive visual representation of Resmed's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Resmed shares. Our platform offers an up-to-date RMD stock price chart, along with technical data analysis and alternative data insights.
Does RMD offer dividends to its shareholders?
Yes, Resmed (RMD) offers dividends to its shareholders, with a dividend yield of 0.99%. This dividend yield represents Resmed's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Resmed in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Resmed?
Some of the similar stocks of Resmed are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.